Journal of Hepato-Biliary-Pancreatic Surgery

, Volume 12, Issue 3, pp 190–195

Stem-cell therapy for hepatobiliary pancreatic disease

Authors

  • Takahisa Fujikawa
    • Department of Pathology, Immunology and Laboratory Medicine and Program in Stem Cell Biology and Regenerative Medicine, College of MedicineUniversity of Florida
  • Seh-Hoon Oh
    • Department of Pathology, Immunology and Laboratory Medicine and Program in Stem Cell Biology and Regenerative Medicine, College of MedicineUniversity of Florida
  • Tom Shupe
    • Department of Pathology, Immunology and Laboratory Medicine and Program in Stem Cell Biology and Regenerative Medicine, College of MedicineUniversity of Florida
  • Bryon E. Petersen
    • Department of Pathology, Immunology and Laboratory Medicine and Program in Stem Cell Biology and Regenerative Medicine, College of MedicineUniversity of Florida
Article

DOI: 10.1007/s00534-005-0982-3

Cite this article as:
Fujikawa, T., Oh, S., Shupe, T. et al. J Hepatobiliary Pancreat Surg (2005) 12: 190. doi:10.1007/s00534-005-0982-3

Abstract

The transplantation of pancreatic beta cells or hepatocytes represents a potential therapeutic approach for type I diabetes and inherited liver diseases, respectively. Furthermore, acquired liver diseases, particularly acute hepatic failure due to toxic or viral injury, have been treated in limited clinical trials with fetal and adult hepatocytes. However, a major limitation is the insufficient amount of beta cells and hepatocytes available for grafts. Alternative sources of these cells have yet to be determined. During the past few years, progress has been made in the development of new strategies to produce mature beta cells and hepatocytes. In this review, we outline the current state of scientific understanding and controversy regarding the properties of embryonic and adult stem cells in the field of hepatobiliary and pancreatic diseases. Our objective is to provide a framework of understanding for the challenges behind translating fundamental stem cell biology into clinical therapies.

Key words

Stem-cell therapyHepatobiliary pancreatic diseaseEmbryonic stem cellBone marrow cellDiabetes mellitus

Copyright information

© Springer-Verlag Tokyo 2005